Literature DB >> 19737549

Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study.

Josefina Martínez1, José M Olmos, José L Hernández, Gabriel Pinedo, Javier Llorca, Eduardo Obregón, Carmen Valero, Jesús González-Macías.   

Abstract

BACKGROUND: This cross-sectional study was performed to determine the reference ranges for two bone turnover markers--aminoterminal propeptide of type I collagen (P1NP) and C-terminal telopeptide of type I collagen (beta-CrossLaps, beta-CTX)--in normal postmenopausal Spanish women as determined in serum by automated methods.
METHODS: A community-based population of 1080 healthy postmenopausal women was evaluated. Data regarding risk factors for osteoporosis and fractures were collected by means of a structured questionnaire. Fasting serum levels of P1NP, beta-CTX, 25-Hydroxivitamin D (25OHD), and intact parathyroid hormone (iPTH) were measured on the Elecsys 2010 automated analyzer (Roche). BMD at lumbar spine, femoral neck and total hip was determined by DXA.
RESULTS: The mean age of subjects was 63+/-9. Logarithmic transformation of both markers was performed to allow for normal distributions. Mid-95% ranges for P1NP and beta-CTX were 19-100 ng/ml and 0.112-1.018 ng/ml, respectively. Mean values of P1NP (47.7+/-19.9 ng/ml) were similar to those previously determined by the manufacturer of the assays, whereas beta-CTX mean values (0.387+/-0.197 ng/ml) were lower. Both markers were higher among osteoporotic women.
CONCLUSIONS: Values obtained from this well-characterized population study provide reference ranges for serum automated P1NP and beta-CTX in normal Spanish postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737549     DOI: 10.1016/j.cca.2009.08.020

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  Nuclear receptor NR5A2 and bone: gene expression and association with bone mineral density.

Authors:  José A Riancho; Yongjun Liu; Jesús Sainz; Miguel A García-Pérez; José M Olmos; Alfonso Bolado-Carrancio; Carmen Valero; Javier Pérez-López; Antonio Cano; Tielin Yang; Carolina Sañudo; Hong-Wen Deng; José C Rodríguez-Rey
Journal:  Eur J Endocrinol       Date:  2011-11-02       Impact factor: 6.664

2.  [Inter-observer agreement in the radiological diagnosis of abdominal aortic calcification (The Camargo Cohort)].

Authors:  Emilio Pariente-Rodrigo; Jesús Castillo-Obeso; José L Hernández-Hernández; José M Olmos-Martínez; Pilar García-Velasco; Rosa Landeras-Alvaro; Ana B García-Garrido
Journal:  Aten Primaria       Date:  2011-04-22       Impact factor: 1.137

3.  Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study.

Authors:  N Guañabens; J M Olmos; J L Hernández; D Cerdà; C Hidalgo Calleja; J A Martinez López; L Arboleya; F J Aguilar Del Rey; S Martinez Pardo; I Ros Vilamajó; X Suris Armangué; D Grados; C Beltrán Audera; E Suero-Rosario; I Gómez Gracia; A Salmoral Chamizo; I Martín-Esteve; H Florez; A Naranjo; S Castañeda; S Ojeda Bruno; S García Carazo; A García Vadillo; L López Vives; À Martínez-Ferrer; H Borrell Paños; P Aguado Acín; R Castellanos-Moreira; C Tebé; C Gómez-Vaquero
Journal:  Osteoporos Int       Date:  2021-01-18       Impact factor: 4.507

4.  No Associations of 25-Hydroxycholecalciferol and Parathyroid Hormone Concentrations with Calcaneal Bone Characteristics in Community-Dwelling Elderly Subjects: A Cross-Sectional Study.

Authors:  A Jungert; M Neuhäuser-Berthold
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

5.  Missense polymorphisms of the WNT16 gene are associated with bone mass, hip geometry and fractures.

Authors:  C García-Ibarbia; M I Pérez-Núñez; J M Olmos; C Valero; M D Pérez-Aguilar; J L Hernández; M T Zarrabeitia; J González-Macías; J A Riancho
Journal:  Osteoporos Int       Date:  2013-02-16       Impact factor: 4.507

Review 6.  Harmonised Australian Reference Intervals for Serum PINP and CTX in Adults.

Authors:  Samuel D Vasikaran; Sa Paul Chubb; Peter R Ebeling; Nicole Jenkins; Graham Rd Jones; Mark A Kotowicz; Howard A Morris; Hans-Gerhard Schneider; Markus J Seibel; Greg Ward
Journal:  Clin Biochem Rev       Date:  2014-11

7.  Distribution of serum βCTX in a population-based study of postmenopausal women taking into account different anti-osteoporotic therapies (the FRODOS Cohort).

Authors:  Eduardo Kanterewicz; Pilar Peris; Emma Puigoriol; Aina Yáñez; Pau Rosique; Luis Del Rio
Journal:  J Bone Miner Metab       Date:  2012-12-08       Impact factor: 2.626

8.  The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.

Authors:  C Gao; J Qiao; S S Li; W J Yu; J W He; W Z Fu; Z L Zhang
Journal:  Osteoporos Int       Date:  2016-07-28       Impact factor: 4.507

9.  Bone mineral density in statin users: a population-based analysis from a Spanish cohort.

Authors:  José L Hernández; José M Olmos; Galo Romaña; Josefina Martinez; Jesús Castillo; Irina Yezerska; Gabriel Pinedo; Jesús González-Macías
Journal:  J Bone Miner Metab       Date:  2013-06-20       Impact factor: 2.626

10.  Establishing reference intervals for bone turnover markers in healthy postmenopausal women in a nonfasting state.

Authors:  Fatma Gossiel; Judith Finigan; Richard Jacques; David Reid; D Felsenberg; Christian Roux; Claus Glueer; Richard Eastell
Journal:  Bonekey Rep       Date:  2014-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.